MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617077473 A) filed by Universitat De Barcelona; Fundaci De Recerca Clnic Barcelona-Institut; and Hospital Clnic De Barcelona on June 23, 2026, for Cd7 Targeting Moieties For The Treatment Of Cd7 Positive Cancer.
Inventors include Guedn Carri, Sonia; Juan Otero, Manuel; Delgado Gonzlez, Julio; Urbano Ispizua, Lvaro; Uribe Herranz, Mireia; Ortiz De Landazuri Pascal, Iaki; Soria Castellano, Marta; and Gimnez Alejandre, Marta.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present invention relates to a CD7 targeting moiety, wherein the CD7 targeting moiety is an antibody, F(ab')2, Fab, scFab or scFv. The present invention further provides CD7 retention domains, CARs, nucleic acid, cells, pharmaceutical compositions and kits comprising the CD7 targeting moiety. Lastly, methods of treatment of a CD7-positive cancer, preferably T-ALL are also provided.
Disclaimer: Curated by HT Syndication.
